INTERNATIONAL BIOTECHNOLOGY TRUST PLC - INTERCEPT PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 160 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2022$32,000,000
+2268.6%
441
-96.0%
0.33%
-34.9%
Q2 2017$1,351,000
+7.1%
11,1550.0%0.51%
+6.2%
Q1 2017$1,262,000
-60.7%
11,155
-62.3%
0.48%
-66.6%
Q4 2016$3,211,000–29,555–1.45%–
 Download
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q3 2022
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders